NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/10/2021
Back to search
Official data from USPTO
ISSAR PHARMACEUTICALS PVT.LTD.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
03/10/2021
Trademark type
Combined
Nice classes
5
Filing date
04/09/2010
Registration date
05/24/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/10/2021
Last transaction
03/10/2021
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
02/01/1995
First use in commerce
02/01/1995
Drawing code
3
Owner type
16
Owner location
Warren, NJ
Examiner
REIHNER, DAVID
Law office
M20
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of a diagonal bar and an oval forming the letters "IP" and wording "Issar Pharmaceuticals Pvt. Ltd.".
Holders and representatives
Holders
I. L. (pessoa física)
Representatives
John Dodds DODDS AND ASSOCIATES
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Peptide based pharmaceutical preparations for the treatment of tumorsmelanomasviral infectionswounds
Publications
History of USPTO decisions and trademark events.
34 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/10/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/10/2021
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
03/09/2021
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
08/15/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/15/2020
E89R
TEAS SECTION 8 & 9 RECEIVED
06/25/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/24/2020
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
06/15/2016
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
06/15/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/10/2016
ES8R
TEAS SECTION 8 RECEIVED
05/26/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
05/24/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/08/2011
PUBO
PUBLISHED FOR OPPOSITION
03/08/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/28/2011
ALIE
ASSIGNED TO LIE
01/28/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/28/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/06/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/06/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/06/2010
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/30/2010
GNRT
NON-FINAL ACTION E-MAILED
09/30/2010
CNRT
NON-FINAL ACTION WRITTEN
09/30/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/24/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/24/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/24/2010
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/15/2010
GNRT
NON-FINAL ACTION E-MAILED
07/15/2010
CNRT
NON-FINAL ACTION WRITTEN
07/15/2010
DOCK
ASSIGNED TO EXAMINER
07/15/2010
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
04/15/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/14/2010
NWAP
NEW APPLICATION ENTERED
04/13/2010
Continuous trademark protection
Get notified about every new filing that threatens ISSAR PHARMACEUTICALS PVT.LTD. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.